Kristen Hook
Pediatric Dermatology · Minneapolis, MNNPI 1053465641
Payments from drug & device makers
Across 112 payments — averaging $866.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amryt Pharma Holdings Ltd$96K
- Pfizer$320
- Regeneron Healthcare Solutions, Inc.$111
- Sanofi$99
- LEO Pharma Inc.$71
- Blueprint Medicines Corporation$60
- plus $300 from 14 others
What the payments were for
- Speaking & faculty fees$12513%
- Food & beverage$83587%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amryt Pharma Holdings Ltd | 67 | $96,102 |
| Pfizer | 9 | $320 |
| Regeneron Healthcare Solutions, Inc. | 7 | $111 |
| Sanofi | 4 | $99 |
| LEO Pharma Inc. | 5 | $71 |
| Blueprint Medicines Corporation | 2 | $60 |
| Incyte Corporation | 3 | $55 |
| Dermavant Sciences, Inc. | 2 | $33 |
| Sun Pharmaceutical Industries Inc. | 1 | $32 |
| Dermira, Inc. | 2 | $29 |
| Boehringer Ingelheim | 1 | $21 |
| Amgen | 1 | $18 |
| Bristol Myers Squibb | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Biofrontera Inc. | 1 | $15 |
| Springworks Therapeutics, Inc. | 1 | $14 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
| Smith+Nephew | 1 | $13 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EUCRISA$125
How this compares
Too few pediatric dermatology providers in Minnesotato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyjuvekBeremagene Geperpavec-Svdt | 48 | $1,158,357 |
Paid to pharmacies, not to this prescriber.
Other pediatric dermatology in Minneapolis
- Christina BoullMinneapolis$5K
- Ingrid PolcariMinneapolis$1K
- Cynthia NicholsonMinneapolis$290
- Sheilagh MaguinessMaple Grove$34K
- Sarah AschSaint Paul$5K
- Jennifer DaySt Louis Park$191
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.